AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 36215947 — intervention group
Group type: EXPERIMENTAL
Intervention: Trivalent ganglioside vaccine targeting GM2, GD2 and GD3 combined with immunological adjuvant OPT-821
Number of subjects: 136
Study 36215947 — intervention group
Group type: COMPARATOR
Intervention: OPT-821 alone (adjuvant only)
Number of subjects: 136
Study 33938673 — intervention group
Group type: EXPERIMENTAL
Intervention: Updated SedLine® algorithm (v.2000)
Number of subjects: 33
Study 33938673 — intervention group
Group type: COMPARATOR
Intervention: Old SedLine® algorithm (v.1203)
Number of subjects: 33
Study 32609805 — intervention group
Group type: EXPERIMENTAL
Intervention: The Safety Class, an abuse prevention group program
Number of subjects: 170
Study 32609805 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 170
Study 35414106 — intervention group
Group type: EXPERIMENTAL
Intervention: Placebo
Number of subjects: 476
Study 35414106 — intervention group
Group type: COMPARATOR
Intervention: Esomeprazole 20 mg (control group)
Number of subjects: 476
Study 34011047 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 layer (120-150 μm) of allogeneic lamellar corneal tissue as the graft (Group A)
Number of subjects: 328
Study 34011047 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 layers of lamellar corneal tissue from one donor (Group B)
Number of subjects: 328
Study 34011047 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 layers of lamellar corneal tissue from 2 donors (Group C)
Number of subjects: 328
Study 32798261 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg saffron daily for 12 weeks
Number of subjects: 76
Study 32798261 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 76
Study 35125131 — intervention group
Group type: EXPERIMENTAL
Intervention: GtACH programme
Number of subjects: 1657
Study 35125131 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 1657
Study 34154669 — intervention group
Group type: EXPERIMENTAL
Intervention: Willingness to engage in romantic love and marital relationships with persons with disabilities
Number of subjects: 403
Study 34154669 — intervention group
Group type: EXPERIMENTAL
Intervention: Fear of reaction from family members
Number of subjects: 403
Study 34154669 — intervention group
Group type: EXPERIMENTAL
Intervention: Sex of respondents
Number of subjects: 403
Study 34154669 — intervention group
Group type: EXPERIMENTAL
Intervention: Raised-up area of respondents
Number of subjects: 403
Study 34154669 — intervention group
Group type: EXPERIMENTAL
Intervention: Age of respondents
Number of subjects: 403
Study 34154669 — intervention group
Group type: EXPERIMENTAL
Intervention: Presence of a person with disability in the family
Number of subjects: 403
Study 33213066 — intervention group
Group type: EXPERIMENTAL
Intervention: Seawater Pizza (SWP)
Number of subjects: 12
Study 33213066 — intervention group
Group type: COMPARATOR
Intervention: Standard traditional Pizza (StP)
Number of subjects: 12
Study 34327187 — intervention group
Group type: EXPERIMENTAL
Intervention: Couple-based collaborative management model (CCMM)
Number of subjects: 36
Study 34327187 — intervention group
Group type: COMPARATOR
Intervention: Patient-only control arm
Number of subjects: 36
Study 32133688 — intervention group
Group type: EXPERIMENTAL
Intervention: Open cohort sampling structure
Number of subjects: 0
Study 32133688 — intervention group
Group type: COMPARATOR
Intervention: Closed cohort sampling structure
Number of subjects: 0
Study 35653744 — intervention group
Group type: EXPERIMENTAL
Intervention: Interpersonal psychotherapy-trauma (IPT-T)
Number of subjects: 162
Study 35653744 — intervention group
Group type: COMPARATOR
Intervention: Clinic psychotherapy (CP)
Number of subjects: 162
Study 33049235 — intervention group
Group type: EXPERIMENTAL
Intervention: VUR/BBD
Number of subjects: 7
Study 33049235 — intervention group
Group type: COMPARATOR
Intervention: VUR
Number of subjects: 7
Study 34156181 — intervention group
Group type: EXPERIMENTAL
Intervention: WBV (whole-body vibration) before RSA and during recovery between sets
Number of subjects: 11
Study 34156181 — intervention group
Group type: COMPARATOR
Intervention: WBV-without (warm-up and passive recovery)
Number of subjects: 11
Study 34156181 — intervention group
Group type: EXPERIMENTAL
Intervention: WBV (whole-body vibration) during recovery
Number of subjects: 11
Study 33300682 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced Homestead Food Production programme
Number of subjects: 0
Study 33300682 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 35279213 — intervention group
Group type: EXPERIMENTAL
Intervention: Rusk-like biscuit powder with hen's egg (HE), cow’s milk (CM), peanut (PN), and hazelnut (HN) (initially approximately 2 mg of each food protein) for 6–8 months.
Number of subjects: 150
Study 35279213 — intervention group
Group type: COMPARATOR
Intervention: Placebo group receiving rusk-like biscuit powder without HE, CM, PN, and HN on a daily basis.
Number of subjects: 150
Study 35279213 — intervention group
Group type: EXPERIMENTAL
Intervention: Rusk-like biscuit powder with HE, CM, PN, and HN.
Number of subjects: 150
Study 35279213 — intervention group
Group type: COMPARATOR
Intervention: Placebo group receiving rusk-like biscuit powder without HE, CM, PN, and HN.
Number of subjects: 150
Study 33822910 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetically predicted short sleep duration (≤6 h)
Number of subjects: 404044
Study 33822910 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetically predicted long sleep duration (≥9 h)
Number of subjects: 404044
Study 34161616 — intervention group
Group type: EXPERIMENTAL
Intervention: Eliglustat therapy
Number of subjects: 40
Study 32104685 — intervention group
Group type: EXPERIMENTAL
Intervention: SNP rs10403848
Number of subjects: 0
Study 32104685 — intervention group
Group type: COMPARATOR
Intervention: SNP rs2043211
Number of subjects: 0
Study 36001700 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-frequency contact ultrasonic debridement (LFCUD) plus polyhexamethylene biguanide (PHMB)
Number of subjects: 50
Study 36001700 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-frequency contact ultrasonic debridement (LFCUD) plus polyhexamethylene biguanidine (PHMB)
Number of subjects: 50
Study 36001700 — intervention group
Group type: COMPARATOR
Intervention: Control group (LFCUD with non-antimicrobial products)
Number of subjects: 50
Study 33639045 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin K2 (100 mcg menaquinone-7) and vitamin D3 (10 mcg calcitriol)
Number of subjects: 29
Study 33639045 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin K2 and vitamin D3
Number of subjects: 29
Study 33639045 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy only (Control)
Number of subjects: 29
Study 32197805 — intervention group
Group type: EXPERIMENTAL
Intervention: Video-based rehabilitation (VBR) group
Number of subjects: 30
Study 32197805 — intervention group
Group type: COMPARATOR
Intervention: Physiotherapist-supervised rehabilitation (PSR) group
Number of subjects: 30
Study 32197805 — intervention group
Group type: COMPARATOR
Intervention: PSR group
Number of subjects: 30
Study 36190994 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone 6 mg daily
Number of subjects: 107
Study 36190994 — intervention group
Group type: COMPARATOR
Intervention: Dexamethasone 20 mg daily
Number of subjects: 107
Study 34275095 — intervention group
Group type: EXPERIMENTAL
Intervention: Derivation cohort with pericarditis score
Number of subjects: 0
Study 34275095 — intervention group
Group type: EXPERIMENTAL
Intervention: Validation group with pericarditis score
Number of subjects: 0
Study 32909921 — intervention group
Group type: EXPERIMENTAL
Intervention: CPAP + OA (oral airway open)
Number of subjects: 16
Study 32909921 — intervention group
Group type: EXPERIMENTAL
Intervention: CPAP + OA (oral airway closed)
Number of subjects: 16
Study 32909921 — intervention group
Group type: COMPARATOR
Intervention: CPAP only
Number of subjects: 16
Study 32909921 — intervention group
Group type: EXPERIMENTAL
Intervention: CPAP + OA (oral airway open) and CPAP + OA (oral airway closed)
Number of subjects: 16
Study 35477531 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified Buzhong Yiqi decoction (MBYD)
Number of subjects: 0
Study 35477531 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 33004230 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher log transformed urinary sodium
Number of subjects: 446237
Study 32227713 — intervention group
Group type: EXPERIMENTAL
Intervention: Yun's optimized pelvic floor training (OPFT) therapy for 6 weeks followed by 6 weeks of traditional pelvic floor muscle exercises (PFME)
Number of subjects: 80
Study 32227713 — intervention group
Group type: COMPARATOR
Intervention: Traditional pelvic floor muscle exercises (PFME) for 6 weeks followed by 6 weeks of Yun's OPFT therapy
Number of subjects: 80
Study 35026375 — intervention group
Group type: EXPERIMENTAL
Intervention: Favipiravir 1800 mg by mouth twice daily on day 1 followed by 800 mg twice daily for 5 to 7 days
Number of subjects: 231
Study 35026375 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 231
Study 35026375 — intervention group
Group type: EXPERIMENTAL
Intervention: Favipiravir
Number of subjects: 231
Study 34198004 — intervention group
Group type: EXPERIMENTAL
Intervention: Karate intervention (Karate Mind and Movement program) for 1 year
Number of subjects: 721
Study 34198004 — intervention group
Group type: COMPARATOR
Intervention: Control group (habitual physical education lessons)
Number of subjects: 721
Study 35444795 — intervention group
Group type: EXPERIMENTAL
Intervention: Pen
Number of subjects: 818
Study 35444795 — intervention group
Group type: EXPERIMENTAL
Intervention: £5 cash
Number of subjects: 818
Study 35444795 — intervention group
Group type: COMPARATOR
Intervention: Control (no pen)
Number of subjects: 818
Study 35444795 — intervention group
Group type: COMPARATOR
Intervention: Control (no £5)
Number of subjects: 818
Study 35606820 — intervention group
Group type: EXPERIMENTAL
Intervention: baricitinib 4mg/day
Number of subjects: 83
Study 35606820 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 83
Study 32250328 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic neuromuscular stabilization (DNS)
Number of subjects: 31
Study 32250328 — intervention group
Group type: COMPARATOR
Intervention: Conventional neurodevelopmental treatment (NDT)
Number of subjects: 31
Study 369727056 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary counselling with probiotics
Number of subjects: 256
Study 369727056 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 256
Study 369727056 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 256
Study 35342931 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard treatment + aprotinin
Number of subjects: 0
Study 35342931 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment
Number of subjects: 0
Study 34514764 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination program including smartphone nutrition education, physical activity (aerobics exercise for 45 minutes three times per week), and cognitive behavioral therapy (CBT) sessions (8 sessions designed for children)
Number of subjects: 62
Study 34514764 — intervention group
Group type: COMPARATOR
Intervention: Traditional education method (lectures by a nutritionist regarding weight management)
Number of subjects: 62
Study 34548479 — intervention group
Group type: EXPERIMENTAL
Intervention: Eribulin + Pembrolizumab
Number of subjects: 88
Study 34548479 — intervention group
Group type: COMPARATOR
Intervention: Eribulin
Number of subjects: 88
Study 34548479 — intervention group
Group type: EXPERIMENTAL
Intervention: ICI-related toxicity
Number of subjects: 88
Study 35045374 — intervention group
Group type: EXPERIMENTAL
Intervention: Motor skill training
Number of subjects: 154
Study 35045374 — intervention group
Group type: COMPARATOR
Intervention: Strength and flexibility exercise
Number of subjects: 154
Study 33164922 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational program with evidence-based messages and web-based interventions (videos and classes) delivered by a multidisciplinary panel of experts.
Number of subjects: 32
Study 32300382 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemical blockage of celiac ganglions by ethanol injection
Number of subjects: 118
Study 32300382 — intervention group
Group type: COMPARATOR
Intervention: Non-injected control group
Number of subjects: 118
Study 35050348 — intervention group
Group type: EXPERIMENTAL
Intervention: Single agent nivolumab
Number of subjects: 29
Study 35050348 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination nivolumab and ipilimumab
Number of subjects: 29
Study 33938676 — intervention group
Group type: EXPERIMENTAL
Intervention: Glidescope videolaryngoscope
Number of subjects: 14
Study 33938676 — intervention group
Group type: COMPARATOR
Intervention: Macintosh direct laryngoscope
Number of subjects: 14
Study 35181470 — intervention group
Group type: EXPERIMENTAL
Intervention: MRI-based radiomics models integrating contours with clinical data
Number of subjects: 110
Study 35181470 — intervention group
Group type: COMPARATOR
Intervention: Traditional TNM staging and clinical data
Number of subjects: 110
Study 32676853 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemotherapy for GI malignancy
Number of subjects: 241
Study 32676853 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre-chemotherapy screening
Number of subjects: 241
Study 32676853 — intervention group
Group type: EXPERIMENTAL
Intervention: Investigations for chemotherapy-induced symptoms
Number of subjects: 241
Study 33170838 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical risk score (0 to 10) based on age, sex, HIV (2 points), diabetes, number of classical TB symptoms (1 point each), and >14‐day symptom duration.
Number of subjects: 701
Study 33170838 — intervention group
Group type: EXPERIMENTAL
Intervention: De novo Ugandan model with similar characteristics to South African model.
Number of subjects: 701
Study 36428060 — intervention group
Group type: EXPERIMENTAL
Intervention: Online laughter therapy (twice weekly for four weeks)
Number of subjects: 61
Study 36428060 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 61
Study 33715056 — intervention group
Group type: EXPERIMENTAL
Intervention: Cement applied on bone surfaces (group 1)
Number of subjects: 90
Study 33715056 — intervention group
Group type: EXPERIMENTAL
Intervention: Cement applied on implant surfaces (group 2)
Number of subjects: 90
Study 33715056 — intervention group
Group type: EXPERIMENTAL
Intervention: Cement applied on both bone and implant surfaces (group 3)
Number of subjects: 90
Study 33715056 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall comparison of cement application techniques
Number of subjects: 90
Study 33715056 — intervention group
Group type: EXPERIMENTAL
Intervention: Cement intrusion in tibia
Number of subjects: 90
Study 33715056 — intervention group
Group type: EXPERIMENTAL
Intervention: Cement amount correlation
Number of subjects: 90
Study 33070132 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin (20 mg/day)
Number of subjects: 84
Study 33070132 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 84
Study 33070132 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin
Number of subjects: 84
Study 36460701 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention aimed at reducing and breaking up sedentary time (InPact, ISRCTN28668090)
Number of subjects: 0
Study 32307227 — intervention group
Group type: EXPERIMENTAL
Intervention: Neuromuscular training (NMT) after paramedical care
Number of subjects: 705
Study 32307227 — intervention group
Group type: EXPERIMENTAL
Intervention: Neuromuscular training (NMT) after secondary care
Number of subjects: 705
Study 32307227 — intervention group
Group type: EXPERIMENTAL
Intervention: Neuromuscular training (NMT) after primary care
Number of subjects: 705
Study 32307227 — intervention group
Group type: EXPERIMENTAL
Intervention: Visiting a physiotherapist
Number of subjects: 705
Study 32307227 — intervention group
Group type: EXPERIMENTAL
Intervention: Use of braces and/or tape during sport after paramedical care
Number of subjects: 705
Study 32307227 — intervention group
Group type: EXPERIMENTAL
Intervention: Use of braces and/or tape during sport after primary care
Number of subjects: 705
Study 32307227 — intervention group
Group type: COMPARATOR
Intervention: Use of braces and/or tape during sport without any care
Number of subjects: 705
Study 35812412 — intervention group
Group type: EXPERIMENTAL
Intervention: WIBP-CorV vaccine (2.5, 5.0, and 10.0μg/dose)
Number of subjects: 816
Study 35812412 — intervention group
Group type: EXPERIMENTAL
Intervention: WIBP-CorV vaccine
Number of subjects: 816
Study 35812412 — intervention group
Group type: COMPARATOR
Intervention: Alum-only control
Number of subjects: 816
Study 35102638 — intervention group
Group type: EXPERIMENTAL
Intervention: PFCs cemented with GIC
Number of subjects: 120
Study 35102638 — intervention group
Group type: COMPARATOR
Intervention: PZCs
Number of subjects: 120
Study 35102638 — intervention group
Group type: EXPERIMENTAL
Intervention: PFCs cemented with RMGIC
Number of subjects: 120
Study 35102638 — intervention group
Group type: COMPARATOR
Intervention: PZCs cemented with GIC
Number of subjects: 120
Study 35102638 — intervention group
Group type: COMPARATOR
Intervention: PZCs cemented with RMGIC
Number of subjects: 120
Study 36349727 — intervention group
Group type: EXPERIMENTAL
Intervention: Monetary incentives provided to community-based volunteers
Number of subjects: 0
Study 34111067 — intervention group
Group type: EXPERIMENTAL
Intervention: Blended learning (BL)
Number of subjects: 59
Study 34111067 — intervention group
Group type: COMPARATOR
Intervention: Face-to-face teaching (f2f)
Number of subjects: 59
Study 32620810 — intervention group
Group type: EXPERIMENTAL
Intervention: Stabilization splint (SS)
Number of subjects: 34
Study 32620810 — intervention group
Group type: COMPARATOR
Intervention: Placebo splint (PS)
Number of subjects: 34
Study 35393915 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital modeling and 3D printing of titanium mesh for thyroid cartilage reconstruction
Number of subjects: 44
Study 35393915 — intervention group
Group type: COMPARATOR
Intervention: Modified crico-hyoido-epiglottopexy (CHEP)
Number of subjects: 44
Study 33433260 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive rehabilitation
Number of subjects: 71
Study 33433260 — intervention group
Group type: COMPARATOR
Intervention: Usual occupational therapy exercises (Control)
Number of subjects: 71
Study 35246387 — intervention group
Group type: EXPERIMENTAL
Intervention: somofilcon A (SiHy)
Number of subjects: 55
Study 35246387 — intervention group
Group type: EXPERIMENTAL
Intervention: etafilcon A (Hy)
Number of subjects: 55
Study 35246387 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined analysis
Number of subjects: 55
Study 32998926 — intervention group
Group type: EXPERIMENTAL
Intervention: Secukinumab 150 mg subcutaneous weekly until week 4, then at week 8; escalated to 300 mg subcutaneous every 4 weeks for non-responders at week 12; switched to adalimumab biosimilar 40 mg subcutaneous every 2 weeks for non-responders at week 24.
Number of subjects: 0
Study 32998926 — intervention group
Group type: COMPARATOR
Intervention: Standard-of-care treatment at the discretion of the physician.
Number of subjects: 0
Study 35043539 — intervention group
Group type: EXPERIMENTAL
Intervention: BioFreedom stent (BF-BES)
Number of subjects: 607
Study 35043539 — intervention group
Group type: COMPARATOR
Intervention: Orsiro stent (O-SES)
Number of subjects: 607
Study 35043539 — intervention group
Group type: EXPERIMENTAL
Intervention: Both stent types
Number of subjects: 607
Study 32826001 — intervention group
Group type: EXPERIMENTAL
Intervention: Breathing retraining and four weekly manual therapy sessions (immediate start)
Number of subjects: 18
Study 32826001 — intervention group
Group type: COMPARATOR
Intervention: Breathing retraining and four weekly manual therapy sessions (delayed start)
Number of subjects: 18
Study 616743252 — intervention group
Group type: EXPERIMENTAL
Intervention: Mother support groups (MSGs) established in 14 clinics, meeting every 2 weeks; Coordinated by volunteer HIV-positive mothers providing health education and reminders via cell phone.
Number of subjects: 348
Study 616743252 — intervention group
Group type: COMPARATOR
Intervention: Control arm (no MSGs) in 13 clinics.
Number of subjects: 348
Study 616743252 — intervention group
Group type: COMPARATOR
Intervention: Overall retention and program outcomes in intervention arm versus control arm.
Number of subjects: 348
Study 35773713 — intervention group
Group type: EXPERIMENTAL
Intervention: Biosimilar denosumab (Arylia)
Number of subjects: 190
Study 35773713 — intervention group
Group type: COMPARATOR
Intervention: Reference denosumab (Prolia®)
Number of subjects: 190
Study 33794854 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient-specific instrumentation (PSI)
Number of subjects: 29
Study 33794854 — intervention group
Group type: COMPARATOR
Intervention: Conventional intermedullary (IM) guides
Number of subjects: 29
Study 32277816 — intervention group
Group type: EXPERIMENTAL
Intervention: EnrichrBot
Number of subjects: 0
Study 36343185 — intervention group
Group type: EXPERIMENTAL
Intervention: Various interventions from 13 multicenter RCTs conducted by PCCS-SG; specific interventions not detailed in the abstract.
Number of subjects: 0
Study 36343185 — intervention group
Group type: EXPERIMENTAL
Intervention: Pilot RCTs as part of the research process; specific details not provided.
Number of subjects: 0
Study 36343185 — intervention group
Group type: EXPERIMENTAL
Intervention: Collaborative research facilitated by a national registry and partnerships with Clinical Trials Units; specific interventions not detailed.
Number of subjects: 0
Study 36343185 — intervention group
Group type: EXPERIMENTAL
Intervention: Involvement of transport teams in trials; specific interventions not detailed.
Number of subjects: 0
Study 36343185 — intervention group
Group type: EXPERIMENTAL
Intervention: Funded infrastructure of clinical research staff within the NHS; specific interventions not detailed.
Number of subjects: 0
Study 36343185 — intervention group
Group type: EXPERIMENTAL
Intervention: Greater international collaboration and embedded trial platforms; specific interventions not detailed.
Number of subjects: 0
Study 34981467 — intervention group
Group type: EXPERIMENTAL
Intervention: Curcuminoids (500 mg/day)
Number of subjects: 72
Study 34981467 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 72
Study 33762239 — intervention group
Group type: EXPERIMENTAL
Intervention: Explanatory model without personalisation (intervention group 1, n=25)
Number of subjects: 75
Study 33762239 — intervention group
Group type: EXPERIMENTAL
Intervention: Explanatory model with elements of personalisation (intervention group 2, n=25)
Number of subjects: 75